Cargando…
MFGE8 is down‐regulated in cardiac fibrosis and attenuates endothelial‐mesenchymal transition through Smad2/3‐Snail signalling pathway
Endothelial‐mesenchymal transition (EndMT) is a major source of transformed cardiac fibroblasts, which is reported to play a key role in cardiac fibrosis (CF), a pathogenesis of cardiovascular diseases such as heart failure, myocardial infarction and atrial fibrillation. Nonetheless, the specific me...
Autores principales: | Wang, Bo, Ge, Zhuowang, Wu, Yan, Zha, Yafang, Zhang, Xuan, Yan, Yexiang, Xie, Yuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686985/ https://www.ncbi.nlm.nih.gov/pubmed/32945126 http://dx.doi.org/10.1111/jcmm.15871 |
Ejemplares similares
-
Identification of MFGE8 in mesenchymal stem cell secretome as an anti-fibrotic factor in liver fibrosis
por: Jang, Yu Jin, et al.
Publicado: (2017) -
Autophagy attenuates endothelial-to-mesenchymal transition by promoting Snail degradation in human cardiac microvascular endothelial cells
por: Zou, Jin, et al.
Publicado: (2017) -
ADAMTS8 Promotes Cardiac Fibrosis Partly Through Activating EGFR Dependent Pathway
por: Zha, Yafang, et al.
Publicado: (2022) -
Mfge8 attenuates human gastric antrum smooth muscle contractions
por: Li, Wen, et al.
Publicado: (2021) -
Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-β1/Smad2/Smad3 pathways
por: Yao, Lixia, et al.
Publicado: (2021)